{"id":"combination-of-prednisone-and-azathioprine","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Bone marrow suppression"},{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Osteoporosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Prednisone is a corticosteroid that broadly suppresses immune cell activation and inflammatory cytokine production. Azathioprine is a purine analog that inhibits T-cell and B-cell proliferation by interfering with nucleotide synthesis. Together, they provide complementary immunosuppression through different mechanisms, commonly used to manage autoimmune and inflammatory conditions.","oneSentence":"This combination suppresses the immune system by reducing corticosteroid-mediated inflammation and blocking T-cell proliferation through azathioprine's purine antagonism.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:06:45.089Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Autoimmune hepatitis"},{"name":"Autoimmune inflammatory conditions requiring immunosuppression"}]},"trialDetails":[{"nctId":"NCT06663943","phase":"PHASE1, PHASE2","title":"A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.","status":"NOT_YET_RECRUITING","sponsor":"Chao Ji","startDate":"2025-10-01","conditions":"Pemphigus Disease, Pemphigus Vulgaris (PV)","enrollment":100},{"nctId":"NCT05965284","phase":"PHASE4","title":"Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)","status":"RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2023-03-09","conditions":"ANCA-associated Vasculitis, Maintenance Therapy","enrollment":40},{"nctId":"NCT04124861","phase":"NA","title":"Withdraw Drug in Stable IgG4-Related Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-06-23","conditions":"Autoimmune Diseases","enrollment":138},{"nctId":"NCT04737343","phase":"NA","title":"Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis","status":"UNKNOWN","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2021-06-30","conditions":"ANCA Associated Vasculitis, Maintenance Therapy","enrollment":114},{"nctId":"NCT00608894","phase":"PHASE2","title":"LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis","status":"TERMINATED","sponsor":"Veloxis Pharmaceuticals","startDate":"2007-12","conditions":"Autoimmune Hepatitis","enrollment":13},{"nctId":"NCT03553472","phase":"","title":"Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2018-01-01","conditions":"Herpes Zoster, Inflammatory Bowel Diseases, Crohn Disease","enrollment":97},{"nctId":"NCT02936375","phase":"PHASE2","title":"The Iguratimod Effect on Lupus Nephritis (IGeLU)","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2017-09-07","conditions":"Lupus Nephritis","enrollment":120},{"nctId":"NCT02294344","phase":"NA","title":"The Clinical Efficacy of DFPP in Patients With AAGN","status":"TERMINATED","sponsor":"Zhi-Hong Liu, M.D.","startDate":"2014-06","conditions":"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis","enrollment":14},{"nctId":"NCT00079183","phase":"PHASE2","title":"Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2002-04","conditions":"Graft Versus Host Disease","enrollment":44},{"nctId":"NCT00774852","phase":"PHASE2","title":"Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-11","conditions":"Lupus Nephritis, Lupus Erythematosus, Systemic","enrollment":137},{"nctId":"NCT01914770","phase":"","title":"Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07","conditions":"Systemic Lupus Erythematosus","enrollment":1016},{"nctId":"NCT01877746","phase":"PHASE3","title":"CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)","status":"UNKNOWN","sponsor":"St. Anne's University Hospital Brno, Czech Republic","startDate":"2013-01","conditions":"Inflammatory Cardiomyopathy","enrollment":234}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1162,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Combination of prednisone and azathioprine","genericName":"Combination of prednisone and azathioprine","companyName":"St. Anne's University Hospital Brno, Czech Republic","companyId":"st-anne-s-university-hospital-brno-czech-republic","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination suppresses the immune system by reducing corticosteroid-mediated inflammation and blocking T-cell proliferation through azathioprine's purine antagonism. Used for Autoimmune hepatitis, Autoimmune inflammatory conditions requiring immunosuppression.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}